What the FDA’s accelerated approval of a new Alzheimer’s drug could mean for those with the disease

January 16, 2023

The U.S. Food and Drug Administration approved the medication lecanemab, sold under the brand name Leqembi, on Jan. 6, 2023, through an “accelerated approval pathway” that fast-tracks promising clinical treatments for diseases in which there are no other currently effective options.

Progress toward cutting racial mortality disparities stalling, reversing
U.S. racial disparities in mortality decreased from 1999 to 2015 for Black men and to 2011 for Black women, followed by stagnation or regression, according to a study published online Sept. 30 in JAMA Network Open.
From kitchenware to toys, household items linked to toxic flame retardants
From toys to kitchenware to food takeout trays, researchers have discovered a toxic chemical banned for its link to cancer in many common household items. Exposure to the flame retardant can come with serious health risks.
US adults in worse health than British counterparts at midlife, finds study
American adults have significantly worse health in midlife compared to their British peers, especially in markers of cardiovascular health, according to a new study involving researchers from Oxford's Leverhulme Centre for Demographic Science, published in the International Journal of Epidemiology.
Botox: Six surprising uses that have nothing to do with smoothing wrinkles
Botulinum toxin, or Botox as it's widely known, is famous for its ability to smooth away wrinkles. But hiding our frown lines from the world isn't the reason early scientists started experimenting with this substance.
Pharma company funding for patient advocacy groups needs to be transparent, says researcher
Patient groups should be playing a central role in Canada's health-care system, advocating for their members by promoting the visibility of their conditions, pushing for more rapid and accurate diagnoses and lobbying for the introduction and funding of new treatments and drugs that may help relieve their members' symptoms and extend their lives.

What the FDA’s accelerated approval of a new Alzheimer’s drug could mean for those with the disease

Recent Posts

JUST IN